INDV
Indivior Pharmaceuticals, Inc.
Stock
$35.71+0.33 (+0.93%)Close Oct 2, 2026
- Operating income, 2025
- $262M
- YoY, 2025
- +589.5%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $262M | +589.5% |
| 2024 | $38M | — |
| 2023 | −$152M | — |
| 2022 | −$77M | — |
| 2021 | $213M | — |